S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Asian stocks mixed as Wall St inches toward bull market
NYSE:CRL

Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts

$201.58
+2.47 (+1.24%)
(As of 06/6/2023 ET)
Compare
Today's Range
$198.51
▼
$202.65
50-Day Range
$183.71
▼
$208.55
52-Week Range
$181.22
▼
$262.00
Volume
324,196 shs
Average Volume
560,422 shs
Market Capitalization
$10.32 billion
P/E Ratio
20.85
Dividend Yield
N/A
Price Target
$260.73
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CRL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Charles River Laboratories International Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20233$2.54$2.79$2.64 
Q2 20233$2.47$3.11$2.72 
Q3 20233$2.24$2.96$2.51 
Q4 20233$2.41$2.53$2.47 
FY 202312$9.66$11.39$10.34 
Q1 20242$2.81$2.82$2.82 
Q2 20242$2.94$2.99$2.97 
Q3 20242$2.69$3.06$2.88 
Q4 20242$2.74$3.22$2.98 
FY 20248$11.18$12.09$11.64 
Q1 20251$3.61$3.61$3.61 

CRL Earnings Date and Information

Charles River Laboratories International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 2nd, 2023 based off prior year's report dates.

Charles River Laboratories International Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/2/2023
(Estimated)		        
2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04 billion$1.10 billion      
11/2/2022Q3 2022$2.51$2.63+$0.12$3.38$978.65 million$989.16 million
8/3/2022Q2 2022$2.74$2.77+$0.03$3.41$995.12 million$973.13 million    
5/4/2022Q1 2022$2.71$2.75+$0.04$3.69$908.64 million$913.93 million      
2/16/2022Q4 2021$2.42$2.49+$0.07$2.31$888.27 million$905.05 million    
11/2/20219/30/2021$2.58$2.70+$0.12$3.39$902.03 million$895.90 million    
8/3/20216/30/2021$2.38$2.61+$0.23$3.50$880.72 million$914.61 million    
5/3/20213/31/2021$2.19$2.53+$0.34$3.86$798.52 million$824.60 million  
2/16/202112/31/2020$2.11$2.39+$0.28$1.97$755.98 million$790.99 million  
10/29/20209/30/2020$1.80$2.33+$0.53$2.63$715.63 million$743.30 million    
8/5/20206/30/2020$1.27$1.58+$0.31$1.82$638.70 million$682.60 million    
5/7/20203/31/2020$1.46$1.84+$0.38$2.66$692.11 million$707.06 million    
2/11/2020Q4 2019$1.83$2.01+$0.18$2.41$685.46 million$691.10 million    
11/6/20199/30/2019$1.64$1.69+$0.05$1.92$674.08 million$668.00 million    
7/31/2019Q2$1.55$1.63+$0.08$2.38$662.61 million$657.60 million  
5/7/20193/31/2019$1.38$1.40+$0.02$1.69$587.65 million$604.57 million  
2/13/201912/31/2018$1.39$1.49+$0.10$1.77$589.86 million$605.53 million  
11/7/20189/30/2018$1.38$1.53+$0.15$1.84$567.58 million$585.30 million    
8/8/2018Q2 2018$1.46$1.62+$0.16$2.14$570.65 million$585.30 million  
5/10/2018Q1 2018$1.26$1.38+$0.12$1.68$480.03 million$493.97 million  
2/13/2018Q4 2017$1.26$1.40+$0.14$3.43$475.02 million$478.50 million  
11/9/2017Q3 2017$1.22$1.30+$0.08$1.52$458.93 million$464.23 million
8/9/2017Q2 2017$1.22$1.29+$0.07$1.46$458.25 million$469.13 million  
5/10/2017Q1 2017$1.1420$1.29+$0.1480$1.61$437.04 million$445.80 million
2/14/2017Q416$1.11$1.21+$0.10$1.49$441.64 million$466.80 million  
11/2/2016Q316$1.13$1.18+$0.05$1.57$291.20 million$425.70 million  
8/3/2016Q216$1.10$1.20+$0.10$1.67$425.05 million$434.10 million  
5/4/2016Q116$0.90$0.98+$0.08$1.18$354.92 million$354.90 million  
2/10/2016Q415$0.94$1.00+$0.06$1.33$349.20 million$353.90 million  
11/4/2015Q315$0.94$1.03+$0.09$1.27$340.09 million$349.50 million  
7/30/2015Q215$0.97$0.96($0.01)$0.90$338.30 million$339.60 million  
4/29/2015Q115$0.82$0.79($0.03)$0.92$324.00 million$320.40 million  
2/10/2015Q414$0.71$0.81+$0.10$1.05$318.73 million$329.50 million  
10/29/2014Q314$0.80$0.86+$0.06$1.04$326.70 million$327.60 million  
8/6/2014Q214$0.82$0.97+$0.15$1.20$327.96 million$341.18 million  
4/30/2014Q114$0.74$0.82+$0.08$0.97$302.08 million$299.40 million  
2/11/2014Q4 2013$0.68$0.73+$0.05$1.06$289.56 million$289.20 million  
10/29/2013Q3 2013$0.70$0.79+$0.09$0.94$290.28 million$292.10 million  
7/31/2013Q2 2013$0.71$0.73+$0.02$0.90$293.77 million$294.40 million  
5/1/2013Q1 2013$0.71$0.69($0.02)$0.85$294.53 million$291.20 million  
2/13/2013Q4 2012$0.60$0.64+$0.04$280.81 million$280.10 million  
10/30/2012$0.62$0.65+$0.03  
8/7/2012$0.66$0.75+$0.09
5/2/2012$0.65$0.70+$0.05  
2/13/2012$0.56$0.69+$0.13  
11/1/2011$0.58$0.57($0.01)
8/2/2011$0.60$0.70+$0.10
5/3/2011$0.55$0.61+$0.06
2/8/2011$0.50$0.60+$0.10
11/3/2010Q3 2010$0.49$0.45($0.04)$1.30
8/2/2010Q2 2010$0.50$0.49($0.01)$0.76
4/26/2010Q1 2010$0.47$0.45($0.02)$0.64
2/8/2010Q4 2009$0.43$0.49+$0.06$0.71
11/3/2009Q3 2009$0.60$0.65+$0.05$0.73
8/4/2009Q2 2009$0.58$0.66+$0.08$0.80
5/5/2009Q1 2009$0.53$0.58+$0.05$0.78
2/9/2009Q4 2008$0.55$0.59+$0.04$11.09
11/5/2008Q3 2008$0.74$0.76+$0.02$0.89
8/5/2008Q2 2008$0.73$0.79+$0.06$0.87
5/6/2008Q1 2008$0.68$0.72+$0.04$0.80
2/11/2008Q4 2007$0.64$0.65+$0.01$0.78












Charles River Laboratories International Earnings - Frequently Asked Questions

When is Charles River Laboratories International's earnings date?

Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 2nd, 2023 based off last year's report dates. Learn more on CRL's earnings history.

How much revenue does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $3.98 billion.

How much profit does Charles River Laboratories International generate each year?

Charles River Laboratories International (NYSE:CRL) has a recorded net income of $486.23 million. CRL has generated $9.67 earnings per share over the last four quarters.

What is Charles River Laboratories International's price-to-earnings ratio?

Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 20.85 and a forward price-to-earnings ratio of 19.57. The price/earnings-to-growth ratio is 1.39.

What is Charles River Laboratories International's EPS forecast for next year?

Charles River Laboratories International's earnings are expected to grow from $10.30 per share to $11.90 per share in the next year, which is a 15.53% increase.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:CRL) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -